Sei Investments CO Dbv Technologies S.A. Transaction History

Sei Investments CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 11, 2018	SELL	$20.86 - $26.6 $521,500 - $665,000	-25,000 Closed	0 $0
Q4 2017 Feb 08, 2018	SELL	$20.9 - $49.36 $209,000 - $493,600	-10,000 Reduced 28.57%	25,000 $615,000
Q3 2017 Nov 06, 2017	BUY	$39.62 - $46.17 $1.39 Million - $1.62 Million	35,000	35,000 $1.49 Million

37.7M

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $145M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.